Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol/fluticasone propionate for airway and systemic inflammation in moderate to severe COPD
ChiCTR-TNC-11001270Phase 4Completed
- Sponsor
- Xinqiao Hospital
- Start
- Sep 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol, fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by Xinqiao Hospital. Started Sep 2009; status: completed.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TNC-11001270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-11001270.